The objectives of the research projects of the laboratory are to define cellular and molecular mechanisms which operate to yield brain damage in cerebrovascular disease, particularly stoke. The long-term objective of the research is, thereby, to contribute to the development of preventive and therapeutic measures against these important diseases. Two types of brain damage are examined: selective neuronal vulnerability and pan- necrosis (infarction). In studying the former we make use not only of models of ischemia, but also of hypoglycemic comas and status epilepticus. Our approach to the latter is inspired by findings showing that three factors can cause transformation of selective neuronal vulnerability into infarction: prolongation of the ischemia, pre-ischemic hyperglycemia with exaggeration of the tissue acidosis, and hyperthermia. The work is experimental, and is based on well-characterized in vivo models of ischemia, as well as of in vitro techniques utilizing primary cultures of neurons and astrocytes.
The specific aim of the present project is to test a hypothesis which predicts that transformation of selective neuronal vulnerability into infarction is, at least in part, secondary to production of free radicals, and that free radical production is enhanced by delocalization of protein-bound iron. We thus assume that prolongation of ischemia, acidosis and hyperthermia all predispose to free radical damage. Three main questions are posed. The first is related to the presumed association between reduced pH and cell damage. The projects addressing this issue will examine the buffer capacity of the whole tissue as well as of neurons and glial cells, attempt defining the sources and location of any acid formed, and study to what extent the damage incurred correlates to changes in intra- or extracellular pH. The second question is whether free radicals are formed under the very conditions in which infarction is induced. This problem will be studied by assessment of the production of partially reduced oxygen species during prolonged ischemia as well as during ischemia complicated by either excessive acidosis or hyperthermia, and by attempts to ameliorate ischemia damage by measures directed against production of free radicals. The third question, finally, is whether there is a coupling between acidosis and release of """"""""catalytic"""""""" iron. This will be studied by measurements of release of bleomycin-reactable iron into cerebrospinal fluid and dialysis fluid, as well as of iron binding in tissue fractions.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS007838-23
Application #
3393671
Study Section
Neurology B Subcommittee 2 (NEUB)
Project Start
1978-07-01
Project End
1994-01-31
Budget Start
1992-02-15
Budget End
1993-01-31
Support Year
23
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Lund University
Department
Type
DUNS #
350582417
City
Lund
State
Country
Sweden
Zip Code
SE-22-100
Yoshimoto, Tetsuyuki; Kristian, Tibor; Hu, Bingren et al. (2002) Effect of NXY-059 on secondary mitochondrial dysfunction after transient focal ischemia; comparison with cyclosporin A. Brain Res 932:99-109
Yoshimoto, Tetsuyuki; Kanakaraj, Palanisamy; Ying Ma, Jing et al. (2002) NXY-059 maintains Akt activation and inhibits release of cytochrome C after focal cerebral ischemia. Brain Res 947:191-8
Janelidze, S; Hu, B R; Siesjo, P et al. (2001) Alterations of Akt1 (PKBalpha) and p70(S6K) in transient focal ischemia. Neurobiol Dis 8:147-54
Yoshimoto, T; Uchino, H; He, Q P et al. (2001) Cyclosporin A, but not FK506, prevents the downregulation of phosphorylated Akt after transient focal ischemia in the rat. Brain Res 899:148-58
Kristian, T; Bernardi, P; Siesjo, B K (2001) Acidosis promotes the permeability transition in energized mitochondria: implications for reperfusion injury. J Neurotrauma 18:1059-74
Ouyang, Y B; He, Q P; Li, P A et al. (2000) Is neuronal injury caused by hypoglycemic coma of the necrotic or apoptotic type? Neurochem Res 25:661-7
Kristian, T; Gertsch, J; Bates, T E et al. (2000) Characteristics of the calcium-triggered mitochondrial permeability transition in nonsynaptic brain mitochondria: effect of cyclosporin A and ubiquinone O. J Neurochem 74:1999-2009
Kuroda, S; Janelidze, S; Siesjo, B K (1999) The immunosuppressants cyclosporin A and FK506 equally ameliorate brain damage due to 30-min middle cerebral artery occlusion in hyperglycemic rats. Brain Res 835:148-53
Kuroda, S; Tsuchidate, R; Smith, M L et al. (1999) Neuroprotective effects of a novel nitrone, NXY-059, after transient focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 19:778-87
Yoshimoto, T; Siesjo, B K (1999) Posttreatment with the immunosuppressant cyclosporin A in transient focal ischemia. Brain Res 839:283-91

Showing the most recent 10 out of 135 publications